Drug Shortages: Accumulating Federal Legislation as an Underlying Cause

Research output: Working paper › peer-review

Standard

Drug Shortages: Accumulating Federal Legislation as an Underlying Cause. / Darrow, Jonathan; Fox, Erin R. ; Minssen, Timo.

2024.

Research output: Working paper › peer-review

Harvard

Darrow, J, Fox, ER & Minssen, T 2024 'Drug Shortages: Accumulating Federal Legislation as an Underlying Cause'.

APA

Darrow, J., Fox, E. R., & Minssen, T. (2024). Drug Shortages: Accumulating Federal Legislation as an Underlying Cause.

Vancouver

Darrow J, Fox ER, Minssen T. Drug Shortages: Accumulating Federal Legislation as an Underlying Cause. 2024.

Author

Darrow, Jonathan ; Fox, Erin R. ; Minssen, Timo. / Drug Shortages: Accumulating Federal Legislation as an Underlying Cause. 2024.

Bibtex

@techreport{c61602b47368437fa5dd7bebeada14ce,
title = "Drug Shortages: Accumulating Federal Legislation as an Underlying Cause",
abstract = "This article considers the role ofwell-intentioned legislation over the past fifty years, including the 1984 HatchWaxman Act, the 2003 Medicare Modernization Act, and 2012 Generic DrugUser Fee Act, and the 2015 Bipartisan Budget Act in inadvertently squeezingprofitability out of the generic drug market and thereby serving as a true rootcause of many drug shortages. Also considered are the potential effects on drugshortages of more recent legislation, including the 2021 American Rescue ActPlan and the 2022 Inflation Reduction Act.",
keywords = "Faculty of Law, drug shortages, Innovation, Access, Prizes",
author = "Jonathan Darrow and Fox, {Erin R.} and Timo Minssen",
year = "2024",
language = "English",
type = "WorkingPaper",

}

RIS

TY - UNPB

T1 - Drug Shortages: Accumulating Federal Legislation as an Underlying Cause

AU - Darrow, Jonathan

AU - Fox, Erin R.

AU - Minssen, Timo

PY - 2024

Y1 - 2024

N2 - This article considers the role ofwell-intentioned legislation over the past fifty years, including the 1984 HatchWaxman Act, the 2003 Medicare Modernization Act, and 2012 Generic DrugUser Fee Act, and the 2015 Bipartisan Budget Act in inadvertently squeezingprofitability out of the generic drug market and thereby serving as a true rootcause of many drug shortages. Also considered are the potential effects on drugshortages of more recent legislation, including the 2021 American Rescue ActPlan and the 2022 Inflation Reduction Act.

AB - This article considers the role ofwell-intentioned legislation over the past fifty years, including the 1984 HatchWaxman Act, the 2003 Medicare Modernization Act, and 2012 Generic DrugUser Fee Act, and the 2015 Bipartisan Budget Act in inadvertently squeezingprofitability out of the generic drug market and thereby serving as a true rootcause of many drug shortages. Also considered are the potential effects on drugshortages of more recent legislation, including the 2021 American Rescue ActPlan and the 2022 Inflation Reduction Act.

KW - Faculty of Law

KW - drug shortages

KW - Innovation

KW - Access

KW - Prizes

M3 - Working paper

BT - Drug Shortages: Accumulating Federal Legislation as an Underlying Cause

ER -

ID: 398910994